Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biosystems and Promega Settle Litigation Over PCR Technology

NEW YORK, Sept. 26 (GenomeWeb News) - Applied Biosystems has settled its litigation with Promega over PCR technology, the company said today.

 

Promega originally sued Hoffman-La Roche and Applera in the US District Court for the Eastern District of Virginia on behalf of the USgovernment but the court dismissed the company's amended complaint with prejudice a year ago. Both Promega and Applera filed appeals at the time, which they have now withdrawn.

 

Promega's suit was based on the False Claims Act, also known as the Informer's Act or the Qui Tam Statute, which allows a private person to sue a person or company that knowingly submits false bills to the federal government.

 

Following the settlement, Promega can now negotiate a license to Roche's PCR patents with ABI, the exclusive licensor of the patents for life science research and applied fields, according to ABI.

 

Earlier in the month, Promega settled its PCR-related litigation with Roche.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.